Skip to content

Beneficient BENF Deferred offering costs

Deferred offering costs at other companies

Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$3.29M-24.2%

Other financials

Income statement

See full
Revenue$18.7M+322%
Operating income$3.9M+141%
Net income$19.9M+331%
EPS (diluted)-$0.49+26.5%

Balance sheet

See full
Cash & equivalents$7.9M+87.3%
Total debt$100.3M-16.6%
Total equity-$128.6M-1,002%
Total assets$337.9M-15.5%

Cash flow

See full
Operating cash flow-$9.4M+6.3%
CapEx$96.0K-85.5%
Free cash flow-$9.4M+6.7%

Valuation

See full
Market cap$52.86M+2,018%
Enterprise value$145.33M+40.6%

Profitability

See full
Operating margin548.5%-323pp
Net margin517.9%-235pp
FCF margin156.8%-40.4pp

Returns & leverage

See full
Return on equity-1,647.1%-2,080pp
Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept us-gaap:DeferredOfferingCosts.

The official record: Beneficient’s 10-K, filed September 29, 2025, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beneficient's deferred offering costs?
Beneficient (BENF) reported deferred offering costs of $0 in Q1 2025.
What is the long-term trend for Beneficient's deferred offering costs?
Over 3 years (2022 to 2025), Beneficient's deferred offering costs has grown at a -100.0% compound annual growth rate (CAGR), from $1.31M to $0.
What does deferred offering costs mean?
These are costs directly attributable to a planned equity or debt offering that are capitalized and deferred until the offering is completed. Once the offering occurs, these costs are typically reclassified as a reduction of the proceeds or amortized over the life of the instrument. This metric provides insight into the company's capital raising activities and associated transaction expenses.